These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
[_]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3177549
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
Incorporation or Organization)
|
Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
Page
|
|
|
|
|
|
|
Financial Statements (Unaudited)
|
|
|
|
|
|
|
a) Condensed Consolidated Statements of Income for the three and nine months ended October 30, 2016 and October 25, 2015
|
|
|
|
|
|
b) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended October 30, 2016 and October 25, 2015
|
|
|
|
|
|
c) Condensed Consolidated Balance Sheets as of October 30, 2016 and January 31, 2016
|
|
|
|
|
|
d) Condensed Consolidated Statements of Cash Flows for the nine months ended October 30, 2016 and October 25, 2015
|
|
|
|
|
|
e) Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
||
|
|
|
Quantitative and Qualitative Disclosures About Market Risk
|
||
|
|
|
Controls and Procedures
|
||
|
|
|
|
|
|
|
|
|
Legal Proceedings
|
||
|
|
|
Risk Factors
|
||
|
|
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
||
|
|
|
Exhibits
|
||
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
2,004
|
|
|
$
|
1,305
|
|
|
$
|
4,737
|
|
|
$
|
3,609
|
|
Cost of revenue
|
821
|
|
|
571
|
|
|
1,977
|
|
|
1,589
|
|
||||
Gross profit
|
1,183
|
|
|
734
|
|
|
2,760
|
|
|
2,020
|
|
||||
Operating expenses
|
|
|
|
|
|
|
|
|
|||||||
Research and development
|
373
|
|
|
329
|
|
|
1,069
|
|
|
987
|
|
||||
Sales, general and administrative
|
171
|
|
|
152
|
|
|
487
|
|
|
441
|
|
||||
Restructuring and other charges
|
—
|
|
|
8
|
|
|
3
|
|
|
97
|
|
||||
Total operating expenses
|
544
|
|
|
489
|
|
|
1,559
|
|
|
1,525
|
|
||||
Income from operations
|
639
|
|
|
245
|
|
|
1,201
|
|
|
495
|
|
||||
Interest income
|
14
|
|
|
9
|
|
|
37
|
|
|
28
|
|
||||
Interest expense
|
(16
|
)
|
|
(12
|
)
|
|
(39
|
)
|
|
(35
|
)
|
||||
Other income (expense), net
|
(16
|
)
|
|
3
|
|
|
(19
|
)
|
|
1
|
|
||||
Income before income tax expense (benefit)
|
621
|
|
|
245
|
|
|
1,180
|
|
|
489
|
|
||||
Income tax expense (benefit)
|
79
|
|
|
(1
|
)
|
|
168
|
|
|
83
|
|
||||
Net income
|
$
|
542
|
|
|
$
|
246
|
|
|
$
|
1,012
|
|
|
$
|
406
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
1.01
|
|
|
$
|
0.45
|
|
|
$
|
1.89
|
|
|
$
|
0.75
|
|
Diluted
|
$
|
0.83
|
|
|
$
|
0.44
|
|
|
$
|
1.59
|
|
|
$
|
0.72
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares used in per share computation:
|
|
|
|
|
|
|
|
|
|
||||||
Basic
|
538
|
|
|
542
|
|
|
536
|
|
|
544
|
|
||||
Diluted
|
653
|
|
|
565
|
|
|
636
|
|
|
563
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Cash dividends declared and paid per common share
|
$
|
0.1150
|
|
|
$
|
0.0975
|
|
|
$
|
0.3450
|
|
|
$
|
0.2800
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
|
|
|
|
||||||||||
Net income
|
$
|
542
|
|
|
$
|
246
|
|
|
$
|
1,012
|
|
|
$
|
406
|
|
Other comprehensive loss, net of tax:
|
|
|
|
|
|
|
|
||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
||||||||
Net unrealized gain (loss) on available-for-sale securities
|
(10
|
)
|
|
3
|
|
|
1
|
|
|
(2
|
)
|
||||
Reclassification adjustments for net realized gain (loss) on available-for-sale securities included in net income
|
—
|
|
|
—
|
|
|
1
|
|
|
(1
|
)
|
||||
Net change in unrealized gain (loss) on available-for-sale securities
|
(10
|
)
|
|
3
|
|
|
2
|
|
|
(3
|
)
|
||||
Cash flow hedges:
|
|
|
|
|
|
|
|
|
|||||||
Net change in unrealized gain (loss) on cash flow hedges
|
2
|
|
|
(3
|
)
|
|
(3
|
)
|
|
(3
|
)
|
||||
Other comprehensive loss, net of tax
|
(8
|
)
|
|
—
|
|
|
(1
|
)
|
|
(6
|
)
|
||||
Total comprehensive income
|
$
|
534
|
|
|
$
|
246
|
|
|
$
|
1,011
|
|
|
$
|
400
|
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,940
|
|
|
$
|
596
|
|
Marketable securities
|
4,731
|
|
|
4,441
|
|
||
Accounts receivable, net
|
833
|
|
|
505
|
|
||
Inventories
|
679
|
|
|
418
|
|
||
Prepaid expenses and other current assets
|
124
|
|
|
93
|
|
||
Total current assets
|
8,307
|
|
|
6,053
|
|
||
Property and equipment, net
|
503
|
|
|
466
|
|
||
Goodwill
|
618
|
|
|
618
|
|
||
Intangible assets, net
|
120
|
|
|
166
|
|
||
Other assets
|
64
|
|
|
67
|
|
||
Total assets
|
$
|
9,612
|
|
|
$
|
7,370
|
|
|
|
|
|
||||
LIABILITIES, CONVERTIBLE DEBT CONVERSION OBLIGATION AND SHAREHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
523
|
|
|
$
|
296
|
|
Accrued and other current liabilities
|
507
|
|
|
642
|
|
||
Convertible debt, short-term
|
1,011
|
|
|
1,413
|
|
||
Total current liabilities
|
2,041
|
|
|
2,351
|
|
||
|
|
|
|
||||
Long-term debt
|
1,982
|
|
|
—
|
|
||
Other long-term liabilities
|
213
|
|
|
453
|
|
||
Capital lease obligations, long-term
|
7
|
|
|
10
|
|
||
Total liabilities
|
4,243
|
|
|
2,814
|
|
||
Commitments and contingencies - see Note 12
|
|
|
|
|
|
||
Convertible debt conversion obligation
|
45
|
|
|
87
|
|
||
Shareholders’ equity:
|
|
|
|
||||
Preferred stock
|
—
|
|
|
—
|
|
||
Common stock
|
1
|
|
|
1
|
|
||
Additional paid-in capital
|
4,581
|
|
|
4,170
|
|
||
Treasury stock, at cost
|
(4,783
|
)
|
|
(4,048
|
)
|
||
Accumulated other comprehensive loss
|
(4
|
)
|
|
(4
|
)
|
||
Retained earnings
|
5,529
|
|
|
4,350
|
|
||
Total shareholders' equity
|
5,324
|
|
|
4,469
|
|
||
Total liabilities, convertible debt conversion obligation and shareholders' equity
|
$
|
9,612
|
|
|
$
|
7,370
|
|
|
Nine Months Ended
|
||||||
|
October 30,
|
|
October 25,
|
||||
|
2016
|
|
2015
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
1,012
|
|
|
$
|
406
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
140
|
|
|
151
|
|
||
Stock-based compensation expense
|
176
|
|
|
145
|
|
||
Deferred income taxes
|
146
|
|
|
107
|
|
||
Amortization of debt discount
|
20
|
|
|
22
|
|
||
Loss on early debt conversions
|
15
|
|
|
—
|
|
||
Net gain on sale and disposal of long-lived assets and investments
|
(2
|
)
|
|
(7
|
)
|
||
Restructuring and other charges
|
—
|
|
|
37
|
|
||
Other
|
8
|
|
|
11
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(328
|
)
|
|
(63
|
)
|
||
Inventories
|
(261
|
)
|
|
59
|
|
||
Prepaid expenses and other assets
|
(28
|
)
|
|
(25
|
)
|
||
Accounts payable
|
218
|
|
|
7
|
|
||
Accrued and other current liabilities
|
(136
|
)
|
|
(41
|
)
|
||
Other long-term liabilities
|
(29
|
)
|
|
(145
|
)
|
||
Net cash provided by operating activities
|
951
|
|
|
664
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Proceeds from sales of marketable securities
|
1,239
|
|
|
1,651
|
|
||
Proceeds from maturities of marketable securities
|
712
|
|
|
872
|
|
||
Proceeds from sale of long-lived assets and investments
|
6
|
|
|
7
|
|
||
Purchases of marketable securities
|
(2,249
|
)
|
|
(2,669
|
)
|
||
Purchases of property and equipment and intangible assets
|
(125
|
)
|
|
(71
|
)
|
||
Reimbursement of headquarters building development costs from banks
|
—
|
|
|
24
|
|
||
Other
|
(3
|
)
|
|
(1
|
)
|
||
Net cash used in investing activities
|
(420
|
)
|
|
(187
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from issuance of debt
|
1,988
|
|
|
—
|
|
||
Payments related to repurchases of common stock
|
(509
|
)
|
|
(452
|
)
|
||
Repayment of convertible debt
|
(444
|
)
|
|
—
|
|
||
Dividends paid
|
(185
|
)
|
|
(152
|
)
|
||
Net proceeds (payments) related to employee stock plans
|
(29
|
)
|
|
99
|
|
||
Payments for debt issuance costs
|
(4
|
)
|
|
—
|
|
||
Payments under capital lease obligations
|
(3
|
)
|
|
(3
|
)
|
||
Other
|
(1
|
)
|
|
5
|
|
||
Net cash provided by (used in) financing activities
|
813
|
|
|
(503
|
)
|
||
Change in cash and cash equivalents
|
1,344
|
|
|
(26
|
)
|
||
Cash and cash equivalents at beginning of period
|
596
|
|
|
497
|
|
||
Cash and cash equivalents at end of period
|
$
|
1,940
|
|
|
$
|
471
|
|
|
|
|
|
||||
Other non-cash activity:
|
|
|
|
||||
Assets acquired by assuming related liabilities
|
$
|
25
|
|
|
$
|
—
|
|
•
|
We recorded excess tax benefits within income tax expense, rather than in APIC, of
$12 million
,
$8 million
and
$42 million
for the first, second and third quarters of fiscal year 2017, respectively.
|
•
|
We recorded a cumulative-effect adjustment as of February 1, 2016 to increase retained earnings by
$353 million
, with a corresponding increase to deferred tax assets, to recognize the net operating loss and federal research tax credit carryforwards attributable to excess tax benefits on stock-based compensation that had not been previously recognized in APIC.
|
•
|
The excess tax benefits are now included in net operating cash rather than net financing cash in our Condensed Consolidated Statements of Cash Flows. We elected to apply this change in presentation prospectively and thus prior periods have not been adjusted.
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||||||||||
|
July 31, 2016
|
|
May 1, 2016
|
|
July 31, 2016
|
||||||||||||||||||
|
As reported
|
|
As adjusted
|
|
As reported
|
|
As adjusted
|
|
As reported
|
|
As adjusted
|
||||||||||||
|
(In millions, except per share data)
|
||||||||||||||||||||||
Condensed Consolidated Statements of Income:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Income tax expense
|
$
|
64
|
|
|
$
|
56
|
|
|
$
|
45
|
|
|
$
|
33
|
|
|
$
|
109
|
|
|
$
|
89
|
|
Net income
|
$
|
253
|
|
|
$
|
261
|
|
|
$
|
196
|
|
|
$
|
208
|
|
|
$
|
449
|
|
|
$
|
469
|
|
Basic net income per share
|
$
|
0.47
|
|
|
$
|
0.49
|
|
|
$
|
0.36
|
|
|
$
|
0.39
|
|
|
$
|
0.84
|
|
|
$
|
0.88
|
|
Diluted net income per share
|
$
|
0.40
|
|
|
$
|
0.41
|
|
|
$
|
0.33
|
|
|
$
|
0.35
|
|
|
$
|
0.73
|
|
|
$
|
0.76
|
|
Weighted average shares used in diluted net income per share computation
|
631
|
|
|
634
|
|
|
597
|
|
|
599
|
|
|
617
|
|
|
620
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Condensed Consolidated Statements of Cash Flows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash provided by operating activities
|
$
|
184
|
|
|
$
|
201
|
|
|
$
|
309
|
|
|
$
|
318
|
|
|
$
|
493
|
|
|
$
|
519
|
|
Net cash used in financing activities
|
$
|
(35
|
)
|
|
$
|
(52
|
)
|
|
$
|
(534
|
)
|
|
$
|
(545
|
)
|
|
$
|
(570
|
)
|
|
$
|
(597
|
)
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
2016 |
|
October 25,
2015 |
|
October 30,
2016 |
|
October 25,
2015 |
||||||||
|
(In millions)
|
||||||||||||||
Cost of revenue
|
$
|
2
|
|
|
$
|
4
|
|
|
$
|
10
|
|
|
$
|
10
|
|
Research and development
|
36
|
|
|
28
|
|
|
95
|
|
|
82
|
|
||||
Sales, general and administrative
|
27
|
|
|
19
|
|
|
71
|
|
|
53
|
|
||||
Total
|
$
|
65
|
|
|
$
|
51
|
|
|
$
|
176
|
|
|
$
|
145
|
|
|
RSUs, PSUs and Market-based PSUs Outstanding
|
|
Options Outstanding
|
||||||||||
|
Number of Shares
|
|
Weighted Average Grant-Date Fair Value Per Share
|
|
Number of Shares
|
|
Weighted Average Exercise Price Per Share
|
||||||
|
(In millions, except per share data)
|
||||||||||||
Balances, January 31, 2016
|
26
|
|
|
$
|
19.12
|
|
|
13
|
|
|
$
|
14.49
|
|
Granted (1) (2)
|
11
|
|
|
$
|
48.88
|
|
|
—
|
|
|
$
|
—
|
|
Exercised
|
—
|
|
|
$
|
—
|
|
|
(4
|
)
|
|
$
|
14.44
|
|
Vested restricted stock
|
(9
|
)
|
|
$
|
17.84
|
|
|
—
|
|
|
$
|
—
|
|
Canceled and forfeited
|
(1
|
)
|
|
$
|
21.58
|
|
|
—
|
|
|
$
|
—
|
|
Balances, October 30, 2016
|
27
|
|
|
$
|
31.76
|
|
|
9
|
|
|
$
|
14.52
|
|
(1)
|
Includes PSUs that will be issued and eligible to vest if the corporate financial performance maximum target level for fiscal year 2017 is achieved. Depending on the actual level of achievement of the corporate performance target at the end of fiscal year 2017, the PSUs issued could range from
0
to
2 million
shares.
|
(2)
|
Includes market-based PSUs that will be issued and eligible to vest if the maximum target for total shareholder return, or TSR, over the 3-year measurement period is achieved. Depending on the ranking of our TSR compared to the respective TSRs of the companies comprising the Standard & Poor’s 500 Index during a 3-year measurement period, the market-based PSUs issued could range from
0
to
0.3 million
shares.
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
|
(In millions)
|
||||||
Aggregate unearned stock-based compensation expense
|
$
|
662
|
|
|
$
|
381
|
|
|
|
|
|
||||
Estimated weighted average amortization period
|
(In years)
|
||||||
Stock options
|
0.7
|
|
|
1.1
|
|
||
RSUs, PSUs and market-based PSUs
|
2.8
|
|
|
2.7
|
|
||
ESPP
|
0.6
|
|
|
0.7
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(In millions, except per share data)
|
||||||||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
542
|
|
|
$
|
246
|
|
|
$
|
1,012
|
|
|
$
|
406
|
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
Basic weighted average shares
|
538
|
|
|
542
|
|
|
536
|
|
|
544
|
|
||||
Dilutive impact of outstanding securities:
|
|
|
|
|
|
|
|
||||||||
Equity awards outstanding
|
27
|
|
|
13
|
|
|
25
|
|
|
13
|
|
||||
1% Convertible Senior Notes
|
45
|
|
|
10
|
|
|
42
|
|
|
6
|
|
||||
Warrants issued with the 1% Convertible Senior Notes
|
43
|
|
|
—
|
|
|
33
|
|
|
—
|
|
||||
Diluted weighted average shares
|
653
|
|
|
565
|
|
|
636
|
|
|
563
|
|
||||
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic (1)
|
$
|
1.01
|
|
|
$
|
0.45
|
|
|
$
|
1.89
|
|
|
$
|
0.75
|
|
Diluted (2)
|
$
|
0.83
|
|
|
$
|
0.44
|
|
|
$
|
1.59
|
|
|
$
|
0.72
|
|
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
|
7
|
|
|
9
|
|
|
9
|
|
|
13
|
|
(1)
|
Calculated as net income divided by basic weighted average shares.
|
(2)
|
Calculated as net income divided by diluted weighted average shares.
|
|
October 30, 2016
|
||||||||||||||
|
Amortized
Cost
|
|
Unrealized
Gain
|
|
Unrealized
Loss
|
|
Estimated
Fair Value
|
||||||||
|
(In millions)
|
||||||||||||||
Corporate debt securities
|
$
|
2,239
|
|
|
$
|
2
|
|
|
$
|
(2
|
)
|
|
$
|
2,239
|
|
Debt securities of United States government agencies
|
1,152
|
|
|
1
|
|
|
(1
|
)
|
|
1,152
|
|
||||
Debt securities issued by United States Treasury
|
770
|
|
|
1
|
|
|
(1
|
)
|
|
770
|
|
||||
Money market funds
|
542
|
|
|
—
|
|
|
—
|
|
|
542
|
|
||||
Asset-backed securities
|
436
|
|
|
1
|
|
|
—
|
|
|
437
|
|
||||
Mortgage-backed securities issued by United States government-sponsored enterprises
|
162
|
|
|
2
|
|
|
(1
|
)
|
|
163
|
|
||||
Foreign government bonds
|
68
|
|
|
—
|
|
|
—
|
|
|
68
|
|
||||
Total
|
$
|
5,369
|
|
|
$
|
7
|
|
|
$
|
(5
|
)
|
|
$
|
5,371
|
|
Classified as:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents
|
|
|
|
|
|
|
|
|
|
$
|
640
|
|
|||
Marketable securities
|
|
|
|
|
|
|
|
|
|
4,731
|
|
||||
Total
|
|
|
|
|
|
|
|
|
|
$
|
5,371
|
|
|
January 31, 2016
|
||||||||||||||
|
Amortized
Cost |
|
Unrealized
Gain |
|
Unrealized
Loss |
|
Estimated
Fair Value |
||||||||
|
(In millions)
|
||||||||||||||
Corporate debt securities
|
$
|
1,903
|
|
|
$
|
1
|
|
|
$
|
(3
|
)
|
|
$
|
1,901
|
|
Debt securities of United States government agencies
|
1,170
|
|
|
1
|
|
|
(1
|
)
|
|
1,170
|
|
||||
Debt securities issued by United States Treasury
|
800
|
|
|
1
|
|
|
—
|
|
|
801
|
|
||||
Asset-backed securities
|
435
|
|
|
—
|
|
|
—
|
|
|
435
|
|
||||
Mortgage-backed securities issued by United States government-sponsored enterprises
|
229
|
|
|
3
|
|
|
(1
|
)
|
|
231
|
|
||||
Foreign government bonds
|
92
|
|
|
—
|
|
|
—
|
|
|
92
|
|
||||
Money market funds
|
43
|
|
|
—
|
|
|
—
|
|
|
43
|
|
||||
Total
|
$
|
4,672
|
|
|
$
|
6
|
|
|
$
|
(5
|
)
|
|
$
|
4,673
|
|
Classified as:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
|
|
|
|
|
|
$
|
232
|
|
||||||
Marketable securities
|
|
|
|
|
|
|
4,441
|
|
|||||||
Total
|
|
|
|
|
|
|
$
|
4,673
|
|
|
Less than 12 months
|
|
12 months or greater
|
|
Total
|
||||||||||||||||||
|
Estimated Fair Value
|
|
Gross
Unrealized
Losses
|
|
Estimated Fair Value
|
|
Gross
Unrealized
Losses
|
|
Estimated Fair Value
|
|
Gross
Unrealized
Losses
|
||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Corporate debt securities
|
$
|
977
|
|
|
$
|
(2
|
)
|
|
$
|
58
|
|
|
$
|
—
|
|
|
$
|
1,035
|
|
|
$
|
(2
|
)
|
Debt securities issued by United States government agencies
|
536
|
|
|
(1
|
)
|
|
27
|
|
|
—
|
|
|
563
|
|
|
(1
|
)
|
||||||
Debt securities issued by the US Treasury
|
197
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
197
|
|
|
(1
|
)
|
||||||
Mortgage-backed securities issued by United States government-sponsored enterprises
|
43
|
|
|
—
|
|
|
36
|
|
|
(1
|
)
|
|
79
|
|
|
(1
|
)
|
||||||
|
$
|
1,753
|
|
|
$
|
(4
|
)
|
|
$
|
121
|
|
|
$
|
(1
|
)
|
|
$
|
1,874
|
|
|
$
|
(5
|
)
|
|
October 30, 2016
|
|
January 31, 2016
|
||||||||||||
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||||||
|
(In millions)
|
||||||||||||||
Less than 1 year
|
$
|
2,346
|
|
|
$
|
2,347
|
|
|
$
|
1,619
|
|
|
$
|
1,619
|
|
Due in 1 - 5 years
|
2,967
|
|
|
2,968
|
|
|
3,019
|
|
|
3,020
|
|
||||
Mortgage-backed securities issued by United States government-sponsored enterprises not due at a single maturity date
|
56
|
|
|
56
|
|
|
34
|
|
|
34
|
|
||||
Total
|
$
|
5,369
|
|
|
$
|
5,371
|
|
|
$
|
4,672
|
|
|
$
|
4,673
|
|
|
|
Estimated Fair Value at
|
|||||||
|
Pricing Category
|
|
October 30, 2016
|
|
January 31, 2016
|
||||
|
|
|
(In millions)
|
||||||
Assets
|
|
|
|
|
|
||||
Cash equivalents and marketable securities:
|
|
|
|
|
|
||||
Corporate debt securities (1)
|
Level 2
|
|
$
|
2,239
|
|
|
$
|
1,901
|
|
Debt securities of United States government agencies (2)
|
Level 2
|
|
$
|
1,152
|
|
|
$
|
1,170
|
|
Debt securities issued by United States Treasury (3)
|
Level 2
|
|
$
|
770
|
|
|
$
|
801
|
|
Money market funds (4)
|
Level 1
|
|
$
|
542
|
|
|
$
|
43
|
|
Asset-backed securities (5)
|
Level 2
|
|
$
|
437
|
|
|
$
|
435
|
|
Mortgage-backed securities issued by United States government-sponsored enterprises (5)
|
Level 2
|
|
$
|
163
|
|
|
$
|
231
|
|
Foreign government bonds (5)
|
Level 2
|
|
$
|
68
|
|
|
$
|
92
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
Liabilities
|
|
|
|
|
|
||||
Current liabilities:
|
|
|
|
|
|
||||
1.00% Convertible Senior Notes (6)
|
Level 2
|
|
$
|
3,725
|
|
|
$
|
2,273
|
|
Other noncurrent liabilities:
|
|
|
|
|
|
||||
2.20% Notes Due 2021 (6)
|
Level 2
|
|
$
|
997
|
|
|
$
|
—
|
|
3.20% Notes Due 2026 (6)
|
Level 2
|
|
$
|
997
|
|
|
$
|
—
|
|
Interest rate swap (7)
|
Level 2
|
|
$
|
9
|
|
|
$
|
7
|
|
(1)
|
Included
$35 million
and
$51 million
in cash equivalents as of
October 30, 2016
and
January 31, 2016
, respectively, and
$2.20 billion
and
$1.85 billion
in marketable securities as of
October 30, 2016
and
January 31, 2016
, respectively, on the Condensed Consolidated Balance Sheets.
|
(2)
|
Included
$38 million
and
$90 million
in cash equivalents as of
October 30, 2016
and
January 31, 2016
, respectively, and
$1.11 billion
and
$1.08 billion
in marketable securities as of
October 30, 2016
and
January 31, 2016
, respectively, on the Condensed Consolidated Balance Sheets.
|
(3)
|
Included
$25 million
in cash equivalents as of
October 30, 2016
and
$745 million
and
$801 million
in marketable securities as of
October 30, 2016
and
January 31, 2016
, respectively, on the Condensed Consolidated Balance Sheets.
|
(4)
|
Reported in cash equivalents on the Condensed Consolidated Balance Sheets.
|
(5)
|
Reported in marketable securities on the Condensed Consolidated Balance Sheets.
|
(6)
|
The Convertible Notes, 2.20% Notes Due 2021, and 3.20% Notes Due 2026 are carried on our Condensed Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs, and are not marked to fair value each period. See Note 11 of these Notes to Condensed Consolidated Financial Statements for additional information.
|
(7)
|
Please refer to
Note 9
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.
|
|
October 30, 2016
|
|
January 31, 2016
|
||||||||||||||||||||
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Acquisition-related intangible assets
|
$
|
193
|
|
|
$
|
(163
|
)
|
|
$
|
30
|
|
|
$
|
193
|
|
|
$
|
(152
|
)
|
|
$
|
41
|
|
Patents and licensed technology
|
469
|
|
|
(379
|
)
|
|
90
|
|
|
462
|
|
|
(337
|
)
|
|
125
|
|
||||||
Total intangible assets
|
$
|
662
|
|
|
$
|
(542
|
)
|
|
$
|
120
|
|
|
$
|
655
|
|
|
$
|
(489
|
)
|
|
$
|
166
|
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
Inventories:
|
(In millions)
|
||||||
Raw materials
|
$
|
203
|
|
|
$
|
105
|
|
Work in-process
|
203
|
|
|
103
|
|
||
Finished goods
|
273
|
|
|
210
|
|
||
Total inventories
|
$
|
679
|
|
|
$
|
418
|
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
Accrued and Other Current Liabilities:
|
(In millions)
|
||||||
Customer related liabilities (1)
|
$
|
175
|
|
|
$
|
160
|
|
Deferred revenue
|
170
|
|
|
322
|
|
||
Accrued payroll and related expenses
|
79
|
|
|
79
|
|
||
Accrued restructuring and other charges (2)
|
13
|
|
|
23
|
|
||
Professional service fees
|
13
|
|
|
23
|
|
||
Coupon interest on notes
|
12
|
|
|
3
|
|
||
Income taxes payable
|
9
|
|
|
2
|
|
||
Warranty accrual (3)
|
8
|
|
|
11
|
|
||
Contributions payable
|
4
|
|
|
3
|
|
||
Leases payable
|
4
|
|
|
4
|
|
||
Accrued royalties
|
4
|
|
|
1
|
|
||
Other
|
16
|
|
|
11
|
|
||
Total accrued and other current liabilities
|
$
|
507
|
|
|
$
|
642
|
|
(1)
|
Customer related liabilities include accrued customer programs, such as rebates and marketing development funds.
|
(2)
|
Please refer to
Note 15
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding restructuring and other charges.
|
(3)
|
Please refer to
Note 10
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding warranties.
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
Other Long-Term Liabilities:
|
(In millions)
|
||||||
Deferred income tax liability (1)
|
$
|
88
|
|
|
$
|
301
|
|
Income taxes payable
|
85
|
|
|
78
|
|
||
Contributions payable
|
13
|
|
|
13
|
|
||
Interest rate swap (2)
|
9
|
|
|
7
|
|
||
Deferred revenue (3)
|
2
|
|
|
44
|
|
||
Other
|
16
|
|
|
10
|
|
||
Total other long-term liabilities
|
$
|
213
|
|
|
$
|
453
|
|
(1)
|
Please refer to the “Recently Adopted Accounting Pronouncement” section of Note 1 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the impact of a recently adopted accounting pronouncement on deferred taxes.
|
(2)
|
Please refer to
Note 9
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.
|
(3)
|
Deferred revenue under our patent cross licensing agreement with Intel Corporation is now located in short term deferred revenue as less than twelve months remains on the agreement.
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
|
(In millions)
|
||||||
Balance at beginning of period
|
$
|
11
|
|
|
$
|
8
|
|
Additions
|
1
|
|
|
27
|
|
||
Deductions
|
(5
|
)
|
|
(24
|
)
|
||
Balance at end of period
|
$
|
7
|
|
|
$
|
11
|
|
|
October 30,
|
|
January 31,
|
||||
|
2016
|
|
2016
|
||||
|
(In millions)
|
||||||
1.00% Convertible Senior Notes Due 2018
|
$
|
1,056
|
|
|
$
|
1,500
|
|
Unamortized debt discount (1)
|
(45
|
)
|
|
(87
|
)
|
||
Net carrying amount
|
$
|
1,011
|
|
|
$
|
1,413
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
(In millions)
|
||||||||||||||
Contractual coupon interest expense
|
|
$
|
3
|
|
|
$
|
4
|
|
|
$
|
10
|
|
|
$
|
11
|
|
Amortization of debt discount and issuance costs
|
|
5
|
|
|
7
|
|
|
20
|
|
|
22
|
|
||||
Total interest expense related to Convertible Notes
|
|
$
|
8
|
|
|
$
|
11
|
|
|
$
|
30
|
|
|
$
|
33
|
|
|
|
Expected
Remaining Term (years)
|
|
Effective
Interest Rate
|
|
October 30,
2016
|
||
|
|
|
|
|
|
(In millions)
|
||
2.20% Notes Due 2021
|
|
4.9
|
|
2.38%
|
|
$
|
1,000
|
|
3.20% Notes Due 2026
|
|
9.9
|
|
3.31%
|
|
1,000
|
|
|
Unamortized debt discount and issuance costs
|
|
|
|
|
|
(18
|
)
|
|
Net carrying amount
|
|
|
|
|
|
$
|
1,982
|
|
|
GPU
|
|
Tegra Processor
|
|
All Other
|
|
Consolidated
|
||||||||
|
(In millions)
|
||||||||||||||
Three Months Ended October 30, 2016
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
1,697
|
|
|
$
|
241
|
|
|
$
|
66
|
|
|
$
|
2,004
|
|
Depreciation and amortization expense
|
$
|
30
|
|
|
$
|
8
|
|
|
$
|
10
|
|
|
$
|
48
|
|
Operating income (loss)
|
$
|
678
|
|
|
$
|
17
|
|
|
$
|
(56
|
)
|
|
$
|
639
|
|
|
|
|
|
|
|
|
|
||||||||
Three Months Ended October 25, 2015
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue
|
$
|
1,110
|
|
|
$
|
129
|
|
|
$
|
66
|
|
|
$
|
1,305
|
|
Depreciation and amortization expense
|
$
|
26
|
|
|
$
|
11
|
|
|
$
|
11
|
|
|
$
|
48
|
|
Operating income (loss)
|
$
|
367
|
|
|
$
|
(65
|
)
|
|
$
|
(57
|
)
|
|
$
|
245
|
|
|
|
|
|
|
|
|
|
||||||||
Nine Months Ended October 30, 2016
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
3,972
|
|
|
$
|
567
|
|
|
$
|
198
|
|
|
$
|
4,737
|
|
Depreciation and amortization expense
|
$
|
87
|
|
|
$
|
22
|
|
|
$
|
31
|
|
|
$
|
140
|
|
Operating income (loss)
|
$
|
1,405
|
|
|
$
|
(35
|
)
|
|
$
|
(169
|
)
|
|
$
|
1,201
|
|
|
|
|
|
|
|
|
|
||||||||
Nine Months Ended October 25, 2015
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
3,009
|
|
|
$
|
402
|
|
|
$
|
198
|
|
|
$
|
3,609
|
|
Depreciation and amortization expense
|
$
|
81
|
|
|
$
|
36
|
|
|
$
|
34
|
|
|
$
|
151
|
|
Operating income (loss)
|
$
|
917
|
|
|
$
|
(164
|
)
|
|
$
|
(258
|
)
|
|
$
|
495
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
2016 |
|
October 25,
2015 |
|
October 30,
2016 |
|
October 25,
2015 |
||||||||
|
(In millions)
|
||||||||||||||
Reconciling items included in "All Other" category:
|
|
|
|
|
|
|
|
||||||||
Unallocated revenue
|
$
|
66
|
|
|
$
|
66
|
|
|
$
|
198
|
|
|
$
|
198
|
|
Stock-based compensation expense
|
(65
|
)
|
|
(51
|
)
|
|
(176
|
)
|
|
(145
|
)
|
||||
Unallocated cost of revenue and operating expenses
|
(53
|
)
|
|
(60
|
)
|
|
(156
|
)
|
|
(181
|
)
|
||||
Acquisition-related costs
|
(4
|
)
|
|
(4
|
)
|
|
(12
|
)
|
|
(18
|
)
|
||||
Restructuring and other charges
|
—
|
|
|
(8
|
)
|
|
(3
|
)
|
|
(97
|
)
|
||||
Contributions
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
||||
Product warranty charge
|
—
|
|
|
—
|
|
|
—
|
|
|
(15
|
)
|
||||
Legal settlement costs
|
—
|
|
|
—
|
|
|
(16
|
)
|
|
—
|
|
||||
Total
|
$
|
(56
|
)
|
|
$
|
(57
|
)
|
|
$
|
(169
|
)
|
|
$
|
(258
|
)
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(In millions)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Taiwan
|
$
|
747
|
|
|
$
|
515
|
|
|
$
|
1,696
|
|
|
$
|
1,348
|
|
China
|
341
|
|
|
229
|
|
|
845
|
|
|
583
|
|
||||
Other Asia Pacific
|
309
|
|
|
181
|
|
|
660
|
|
|
554
|
|
||||
United States
|
282
|
|
|
156
|
|
|
682
|
|
|
474
|
|
||||
Europe
|
171
|
|
|
116
|
|
|
494
|
|
|
341
|
|
||||
Other Americas
|
154
|
|
|
108
|
|
|
360
|
|
|
309
|
|
||||
Total revenue
|
$
|
2,004
|
|
|
$
|
1,305
|
|
|
$
|
4,737
|
|
|
$
|
3,609
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(In millions)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Gaming
|
$
|
1,244
|
|
|
$
|
761
|
|
|
$
|
2,712
|
|
|
$
|
2,008
|
|
Professional Visualization
|
207
|
|
|
190
|
|
|
610
|
|
|
547
|
|
||||
Datacenter
|
240
|
|
|
82
|
|
|
534
|
|
|
242
|
|
||||
Automotive
|
127
|
|
|
79
|
|
|
359
|
|
|
227
|
|
||||
OEM & IP
|
186
|
|
|
193
|
|
|
522
|
|
|
585
|
|
||||
Total revenue
|
$
|
2,004
|
|
|
$
|
1,305
|
|
|
$
|
4,737
|
|
|
$
|
3,609
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
October 30,
|
|
October 25,
|
|
October 30,
|
|
October 25,
|
||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
Revenue:
|
|
|
|
|
|
|
|
||||
Customer A
|
13
|
%
|
|
10
|
%
|
|
12
|
%
|
|
11
|
%
|
|
|
October 30,
|
|
January 31,
|
||
|
|
2016
|
|
2016
|
||
Accounts Receivable:
|
|
|
|
|
||
Customer B
|
|
18
|
%
|
|
21
|
%
|
Customer C
|
|
12
|
%
|
|
3
|
%
|
Balance as of January 31, 2016
|
$
|
23
|
|
Restructuring and other charges
|
3
|
|
|
Cash payments
|
(14
|
)
|
|
Non-cash adjustments
|
1
|
|
|
Balance as of October 30, 2016
|
$
|
13
|
|
|
Three Months Ended
|
|
|
|
|
||||||||||||
|
October 30, 2016
|
|
July 31, 2016
|
|
October 25, 2015
|
|
Q/Q
|
|
Y/Y
|
||||||||
|
(In millions, except per share data)
|
||||||||||||||||
Revenue
|
$
|
2,004
|
|
|
$
|
1,428
|
|
|
$
|
1,305
|
|
|
40
|
%
|
|
54
|
%
|
Gross margin
|
59.0
|
%
|
|
57.9
|
%
|
|
56.3
|
%
|
|
110 bps
|
|
|
270 bps
|
|
|||
Operating expenses
|
$
|
544
|
|
|
$
|
509
|
|
|
$
|
489
|
|
|
7
|
%
|
|
11
|
%
|
Income from operations
|
$
|
639
|
|
|
$
|
317
|
|
|
$
|
245
|
|
|
102
|
%
|
|
161
|
%
|
Net income
|
$
|
542
|
|
|
$
|
261
|
|
|
$
|
246
|
|
|
108
|
%
|
|
120
|
%
|
Net income per diluted share
|
$
|
0.83
|
|
|
$
|
0.41
|
|
|
$
|
0.44
|
|
|
102
|
%
|
|
89
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
October 30,
2016 |
|
October 25,
2015 |
|
October 30,
2016 |
|
October 25,
2015 |
||||
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of revenue
|
41.0
|
|
|
43.7
|
|
|
41.7
|
|
|
44.0
|
|
Gross profit
|
59.0
|
|
|
56.3
|
|
|
58.3
|
|
|
56.0
|
|
Operating expenses
|
|
|
|
|
|
|
|
||||
Research and development
|
18.6
|
|
|
25.2
|
|
|
22.6
|
|
|
27.3
|
|
Sales, general and administrative
|
8.5
|
|
|
11.6
|
|
|
10.3
|
|
|
12.2
|
|
Restructuring and other charges
|
—
|
|
|
0.6
|
|
|
0.1
|
|
|
2.7
|
|
Total operating expenses
|
27.1
|
|
|
37.4
|
|
|
33.0
|
|
|
42.2
|
|
Income from operations
|
31.9
|
|
|
18.9
|
|
|
25.3
|
|
|
13.8
|
|
Interest income
|
0.7
|
|
|
0.7
|
|
|
0.8
|
|
|
0.8
|
|
Interest expense
|
(0.8
|
)
|
|
(0.9
|
)
|
|
(0.8
|
)
|
|
(1.0
|
)
|
Other income (expense), net
|
(0.8
|
)
|
|
0.2
|
|
|
(0.4
|
)
|
|
—
|
|
Income before income tax expense (benefit)
|
31.0
|
|
|
18.9
|
|
|
24.9
|
|
|
13.6
|
|
Income tax expense (benefit)
|
3.9
|
|
|
(0.1
|
)
|
|
3.5
|
|
|
2.3
|
|
Net income
|
27.1
|
%
|
|
19.0
|
%
|
|
21.4
|
%
|
|
11.3
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
|
October 30,
2016 |
|
October 25,
2015 |
|
$
Change |
|
%
Change |
|
October 30,
2016 |
|
October 25,
2015 |
|
$
Change |
|
%
Change |
||||||||||||||
|
(In millions)
|
||||||||||||||||||||||||||||
GPU
|
$
|
1,697
|
|
|
$
|
1,110
|
|
|
$
|
587
|
|
|
53
|
%
|
|
$
|
3,972
|
|
|
$
|
3,009
|
|
|
$
|
963
|
|
|
32
|
%
|
Tegra Processor
|
241
|
|
|
129
|
|
|
112
|
|
|
87
|
%
|
|
567
|
|
|
402
|
|
|
165
|
|
|
41
|
%
|
||||||
All Other
|
66
|
|
|
66
|
|
|
—
|
|
|
—
|
%
|
|
198
|
|
|
198
|
|
|
—
|
|
|
—
|
%
|
||||||
Total
|
$
|
2,004
|
|
|
$
|
1,305
|
|
|
$
|
699
|
|
|
54
|
%
|
|
$
|
4,737
|
|
|
$
|
3,609
|
|
|
$
|
1,128
|
|
|
31
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
October 30,
2016 |
|
October 25,
2015 |
|
October 30,
2016 |
|
October 25,
2015 |
||||
Revenue:
|
|
|
|
|
|
|
|
||||
Customer A
|
13
|
%
|
|
10
|
%
|
|
12
|
%
|
|
11
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
|
October 30,
2016 |
|
October 25,
2015 |
|
$
Change
|
|
%
Change
|
|
October 30,
2016 |
|
October 30,
2015 |
|
$
Change |
|
%
Change |
||||||||||||||
|
(In millions)
|
||||||||||||||||||||||||||||
Research and development expenses
|
$
|
373
|
|
|
$
|
329
|
|
|
$
|
44
|
|
|
13
|
%
|
|
$
|
1,069
|
|
|
$
|
987
|
|
|
$
|
82
|
|
|
8
|
%
|
Sales, general and administrative expenses
|
171
|
|
|
152
|
|
|
19
|
|
|
13
|
%
|
|
487
|
|
|
441
|
|
|
46
|
|
|
10
|
%
|
||||||
Restructuring and other charges
|
—
|
|
|
8
|
|
|
(8
|
)
|
|
(100
|
)%
|
|
3
|
|
|
97
|
|
|
(94
|
)
|
|
(97
|
)%
|
||||||
Total operating expenses
|
$
|
544
|
|
|
$
|
489
|
|
|
$
|
55
|
|
|
11
|
%
|
|
$
|
1,559
|
|
|
$
|
1,525
|
|
|
$
|
34
|
|
|
2
|
%
|
Research and development expenses as a percentage of net revenue
|
19
|
%
|
|
25
|
%
|
|
|
|
|
|
|
|
23
|
%
|
|
27
|
%
|
|
|
|
|
||||||||
Sales, general and administrative expenses as a percentage of net revenue
|
9
|
%
|
|
12
|
%
|
|
|
|
|
|
|
|
10
|
%
|
|
12
|
%
|
|
|
|
|
||||||||
Restructuring and other charges as a percentage of net revenue
|
—
|
%
|
|
1
|
%
|
|
|
|
|
|
—
|
%
|
|
3
|
%
|
|
|
|
|
|
October 30, 2016
|
|
January 31, 2016
|
||||
|
(In millions)
|
||||||
Cash and cash equivalents
|
$
|
1,940
|
|
|
$
|
596
|
|
Marketable securities
|
4,731
|
|
|
4,441
|
|
||
Cash, cash equivalents and marketable securities
|
$
|
6,671
|
|
|
$
|
5,037
|
|
|
Nine Months Ended
|
||||||
|
October 30, 2016
|
|
October 25, 2015
|
||||
|
(In millions)
|
||||||
Net cash provided by operating activities
|
$
|
951
|
|
|
$
|
664
|
|
Net cash used in investing activities
|
$
|
(420
|
)
|
|
$
|
(187
|
)
|
Net cash provided by (used in) financing activities
|
$
|
813
|
|
|
$
|
(503
|
)
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
4.1
|
|
Indenture, dated as of September 16, 2016, by and between NVIDIA Corporation and Wells Fargo Bank, National Association, as Trustee
|
|
8-K
|
|
000-23985
|
|
4.1
|
|
September 16, 2016
|
4.2
|
|
Officers’ Certificate, dated as of September 16, 2016
|
|
8-K
|
|
000-23985
|
|
4.2
|
|
September 16, 2016
|
4.3
|
|
Form of 2021 Note
|
|
8-K
|
|
000-23985
|
|
4.2 (Annex A)
|
|
September 16, 2016
|
4.4
|
|
Form of 2026 Note
|
|
8-K
|
|
000-23985
|
|
4.2 (Annex B)
|
|
September 16, 2016
|
10.1*
|
|
Second Amendment to Participation Agreement dated September 9, 2016 among NVIDIA Land Development, LLC, Wachovia Service Corporation, and Wells Fargo Bank, N.A., and a syndicate of other institutions
|
|
|
|
|
|
|
|
|
10.2
|
|
Credit Agreement, dated as of October 7, 2016 by and among NVIDIA Corporation, Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto
|
|
8-K
|
|
000-23985
|
|
1.1
|
|
October 13, 2016
|
31.1*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.1#*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.2#*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
NVIDIA Corporation
|
||
By:
|
/s/ Colette M. Kress
|
|
|
|
|
|
|
|
Colette M. Kress
|
||
|
Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
4.1
|
|
Indenture, dated as of September 16, 2016, by and between NVIDIA Corporation and Wells Fargo Bank, National Association, as Trustee
|
|
8-K
|
|
000-23985
|
|
4.1
|
|
September 16, 2016
|
4.2
|
|
Officers’ Certificate, dated as of September 16, 2016
|
|
8-K
|
|
000-23985
|
|
4.2
|
|
September 16, 2016
|
4.3
|
|
Form of 2021 Note
|
|
8-K
|
|
000-23985
|
|
4.2 (Annex A)
|
|
September 16, 2016
|
4.4
|
|
Form of 2026 Note
|
|
8-K
|
|
000-23985
|
|
4.2 (Annex B)
|
|
September 16, 2016
|
10.1*
|
|
Second Amendment to Participation Agreement dated September 9, 2016 among NVIDIA Land Development, LLC, Wachovia Service Corporation, and Wells Fargo Bank, N.A., and a syndicate of other institutions
|
|
|
|
|
|
|
|
|
10.2
|
|
Credit Agreement, dated as of October 7, 2016 by and among NVIDIA Corporation, Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto
|
|
8-K
|
|
000-23985
|
|
1.1
|
|
October 13, 2016
|
31.1*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.1#*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.2#*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|